As the CEO of Karyon Bio, Thirunagari introduced the company’s ground breaking Digital Liver initiative, an AI-powered approach to tackling Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
